Page last updated: 2024-10-28

hydroxychloroquine and Myxedema

hydroxychloroquine has been researched along with Myxedema in 1 studies

Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.

Myxedema: A condition characterized by a dry, waxy type of swelling (EDEMA) with abnormal deposits of MUCOPOLYSACCHARIDES in the SKIN and other tissues. It is caused by a deficiency of THYROID HORMONES. The skin becomes puffy around the eyes and on the cheeks. The face is dull and expressionless with thickened nose and lips.

Research Excerpts

ExcerptRelevanceReference
" The antimalarial hydroxychloroquine has a rapid and reliable effect in reticular erythematous mucinosis."3.72Treatment of scleromyxoedema with hydroxychloroquine. ( Becker, JC; Bröcker, EB; Kahaly, GJ; Lurz, C; Terheyden, P, 2003)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Terheyden, P1
Becker, JC1
Lurz, C1
Kahaly, GJ1
Bröcker, EB1

Other Studies

1 other study available for hydroxychloroquine and Myxedema

ArticleYear
Treatment of scleromyxoedema with hydroxychloroquine.
    Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2003, Volume: 1, Issue:1

    Topics: Adult; Dermatologic Agents; Erythema; Female; Humans; Hydroxychloroquine; Male; Middle Aged; Myxedem

2003